Literature DB >> 29860102

Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.

Flavia Lambertucci1, Ainelén Arboatti1, María Guillermina Sedlmeier1, Omar Motiño2, María de Luján Alvarez1, María Paula Ceballos1, Silvina R Villar3, Eduardo Roggero3, Juan A Monti1, Gerardo Pisani4, Ariel D Quiroga1, Paloma Martín-Sanz5, Cristina Ester Carnovale1, Daniel Eleazar Francés1, María Teresa Ronco6.   

Abstract

Obesity is accompanied by a low-grade inflammation state, characterized by increased proinflammatory cytokines levels such as tumor necrosis factor alpha (TNFα) and interleukin-1 beta (IL-1β). In this regard, there exists a lack of studies in hepatic tissue about the role of TNFα receptor 1 (TNFR1) in the context of obesity and insulin resistance during the progression of nonalcoholic fatty liver disease (NAFLD). The aim of this work was to evaluate the effects of high-caloric feeding (HFD) (40% fat, for 16 weeks) on liver inflammation-induced apoptosis, insulin resistance, hepatic lipid accumulation and its progression toward nonalcoholic steatohepatitis (NASH) in TNFR1 knock-out and wild-type mice. Mechanisms involved in HFD-derived IL-1β release and impairment of insulin signaling are still unknown, so we determined whether IL-1β affects liver insulin sensitivity and apoptosis through TNFα receptor 1 (TNFR1)-dependent pathways. We showed that knocking out TNFR1 induces an enhanced IL-1β plasmatic release upon HFD feed. This was correlated with higher hepatic and epididymal white adipose tissue mRNA levels. In vivo and in vitro assays confirmed an impairment in hepatic insulin signaling, in part due to IL-1β-induced decrease of AKT activation and diminution of IRS1 levels, followed by an increase in inflammation, macrophage (resident and recruited) accumulation, hepatocyte apoptotic process and finally hepatic damage. In addition, TNFR1 KO mice displayed higher levels of pro-fibrogenic markers. TNFR1 signaling disruption upon an HFD leads to an accelerated progression from simple steatosis to a more severe phenotype with many NASH features, pointing out a key role of TNFR1 in NAFLD progression.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  High-fat diet; IL-1 beta; IRS1; Inflammation; Insulin resistance; Nonalcoholic liver disease; TNFR1

Mesh:

Substances:

Year:  2018        PMID: 29860102     DOI: 10.1016/j.jnutbio.2018.04.013

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  10 in total

Review 1.  Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer.

Authors:  Rosa Divella; Antonio Mazzocca; Antonella Daniele; Carlo Sabbà; Angelo Paradiso
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

2.  The long-term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high-fructose-fed adolescent rats.

Authors:  Kasimu G Ibrahim; Eliton Chivandi; Pilani Nkomozepi; Mashudu G Matumba; Emmanuel Mukwevho; Kennedy H Erlwanger
Journal:  Physiol Rep       Date:  2019-03

Review 3.  Extracellular Vesicles as Inflammatory Drivers in NAFLD.

Authors:  Akshatha N Srinivas; Diwakar Suresh; Prasanna K Santhekadur; Deepak Suvarna; Divya P Kumar
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

Review 4.  Human Gut Microbiome and Liver Diseases: From Correlation to Causation.

Authors:  Rui Li; Zhengsheng Mao; Xujun Ye; Tao Zuo
Journal:  Microorganisms       Date:  2021-05-08

5.  Participation of 5-lipoxygenase and LTB4 in liver regeneration after partial hepatectomy.

Authors:  Florencia Lorenzetti; Marina Cecilia Vera; María Paula Ceballos; María Teresa Ronco; Gerardo Bruno Pisani; Juan Alberto Monti; Alvaro Lucci; Carla Gabriela Comanzo; Thierry Tordjmann; María Cristina Carrillo; Ariel Darío Quiroga; María de Luján Alvarez
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

6.  Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms.

Authors:  Ricardo Rodríguez-Calvo; Sara Samino; Josefa Girona; Neus Martínez-Micaelo; Pere Ràfols; María García-Altares; Sandra Guaita-Esteruelas; Alexandra Junza; Mercedes Heras; Oscar Yanes; Xavier Correig; Lluis Masana
Journal:  Biomolecules       Date:  2020-09-03

Review 7.  Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Authors:  Patricia Rada; Águeda González-Rodríguez; Carmelo García-Monzón; Ángela M Valverde
Journal:  Cell Death Dis       Date:  2020-09-25       Impact factor: 8.469

8.  Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice.

Authors:  Sena Bluemel; Yanhan Wang; Suhan Lee; Bernd Schnabl
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

Review 9.  Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease.

Authors:  Juan Moreno-Vedia; Josefa Girona; Daiana Ibarretxe; Lluís Masana; Ricardo Rodríguez-Calvo
Journal:  Biomedicines       Date:  2022-01-17

10.  Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients?

Authors:  Masoudreza Sohrabi; Ali Gholami; Bahareh Amirkalali; Mahsa Taherizadeh; Mahsa Kolahdoz; Fahimeh SafarnezhadTameshkel; Sheida Aghili; Marzieh Hajibaba; Farhad Zamani; Mohsen Nasiri Toosi; Hossein Keyvani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.